Wall Street brokerages expect Intuitive Surgical (NASDAQ:ISRG) to post earnings per share (EPS) of $1.99 for the current fiscal quarter, according to Zacks. Five analysts have made estimates for Intuitive Surgical’s earnings, with the highest EPS estimate coming in at $2.18 and the lowest estimate coming in at $1.64. Intuitive Surgical posted earnings per share of $1.70 during the same quarter last year, which would indicate a positive year-over-year growth rate of 17.1%. The company is scheduled to announce its next quarterly earnings results after the market closes on Tuesday, April 17th.
According to Zacks, analysts expect that Intuitive Surgical will report full-year earnings of $9.61 per share for the current financial year, with EPS estimates ranging from $9.37 to $10.00. For the next financial year, analysts expect that the company will post earnings of $10.82 per share, with EPS estimates ranging from $9.53 to $11.98. Zacks’ EPS calculations are a mean average based on a survey of analysts that follow Intuitive Surgical.
Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, January 25th. The medical equipment provider reported $2.54 EPS for the quarter, beating the Zacks’ consensus estimate of $2.27 by $0.27. The firm had revenue of $892.40 million for the quarter, compared to analyst estimates of $866.54 million. Intuitive Surgical had a return on equity of 19.93% and a net margin of 21.09%. Intuitive Surgical’s revenue for the quarter was up 17.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.03 earnings per share.
In other Intuitive Surgical news, CEO Gary S. Guthart sold 28,525 shares of the company’s stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $414.50, for a total value of $11,823,612.50. Following the sale, the chief executive officer now owns 311,469 shares in the company, valued at approximately $129,103,900.50. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Marshall Mohr sold 7,500 shares of the company’s stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $414.19, for a total value of $3,106,425.00. Following the completion of the sale, the chief financial officer now owns 13,816 shares in the company, valued at approximately $5,722,449.04. The disclosure for this sale can be found here. In the last 90 days, insiders sold 102,770 shares of company stock worth $43,410,836. Insiders own 2.20% of the company’s stock.
Large investors have recently made changes to their positions in the company. Point72 Asset Management L.P. purchased a new position in shares of Intuitive Surgical during the 3rd quarter valued at approximately $24,264,000. Chevy Chase Trust Holdings Inc. lifted its position in shares of Intuitive Surgical by 206.2% during the 4th quarter. Chevy Chase Trust Holdings Inc. now owns 179,792 shares of the medical equipment provider’s stock valued at $65,613,000 after buying an additional 121,082 shares in the last quarter. Atria Investments LLC lifted its position in shares of Intuitive Surgical by 189.4% during the 4th quarter. Atria Investments LLC now owns 1,777 shares of the medical equipment provider’s stock valued at $648,000 after buying an additional 1,163 shares in the last quarter. Shaker Investments LLC OH lifted its position in shares of Intuitive Surgical by 200.0% during the 4th quarter. Shaker Investments LLC OH now owns 2,100 shares of the medical equipment provider’s stock valued at $766,000 after buying an additional 1,400 shares in the last quarter. Finally, Gulf International Bank UK Ltd lifted its position in shares of Intuitive Surgical by 200.0% during the 4th quarter. Gulf International Bank UK Ltd now owns 35,841 shares of the medical equipment provider’s stock valued at $13,079,000 after buying an additional 23,894 shares in the last quarter. Hedge funds and other institutional investors own 87.89% of the company’s stock.
NASDAQ ISRG traded down $0.42 during trading hours on Friday, reaching $414.63. The stock had a trading volume of 470,072 shares, compared to its average volume of 753,555. The firm has a market cap of $46,926.42, a P/E ratio of 57.67, a P/E/G ratio of 4.94 and a beta of 0.57. Intuitive Surgical has a 52-week low of $251.13 and a 52-week high of $452.00.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.